StockData
Hepion Pharmaceuticals, Inc. logo

Hepion Pharmaceuticals, Inc. (HEPA) stock

HEPAOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as CTRVP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 17, 2026Score 1/30
$0.10−0.00 (-1.45%)

Close on Oct 19, 2026Market cap $7.26MP/E –Yield –

Hepion Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Hepion Pharmaceuticals's ebitda for the twelve months ending Dec 31, 2024 was -$19.32M. For fiscal 2024 it was -$19.32M. The highest annual figure on record is -$1.67M in fiscal 2014.

Annual ebitda

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$19.32M–
FY2023Dec 31, 2023-$48.38M–
FY2022Dec 31, 2022-$45.41M–
FY2021Dec 31, 2021-$30.32M–
FY2020Dec 31, 2020-$20.11M–
FY2019Dec 31, 2019-$7.74M–
FY2017Jun 30, 2017-$21.00M–
FY2016Jun 30, 2016-$20.78M–
FY2015Jun 30, 2015-$13.94M–
FY2014Jun 30, 2014-$1.67M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ4 2024Dec 31, 2024-$1.20M–
Q3 FY2024CQ3 2024Sep 30, 2024-$4.46M–
Q2 FY2024CQ2 2024Jun 30, 2024-$8.50M–
Q1 FY2024CQ1 2024Mar 31, 2024-$5.15M–
Q4 FY2023CQ4 2023Dec 31, 2023-$10.40M–
Q3 FY2023CQ3 2023Sep 30, 2023-$10.65M–
Q2 FY2023CQ2 2023Jun 30, 2023-$14.15M–
Q1 FY2023CQ1 2023Mar 31, 2023-$13.19M–
Q4 FY2022CQ4 2022Dec 31, 2022-$9.75M–
Q3 FY2022CQ3 2022Sep 30, 2022-$8.45M–
Q2 FY2022CQ2 2022Jun 30, 2022-$19.98M–
Q1 FY2022CQ1 2022Mar 31, 2022-$7.23M–
Q4 FY2021CQ4 2021Dec 31, 2021-$8.98M–
Q3 FY2021CQ3 2021Sep 30, 2021-$8.49M–
Q2 FY2021CQ2 2021Jun 30, 2021-$6.83M–
Q1 FY2021CQ1 2021Mar 31, 2021-$6.01M–
Q4 FY2020CQ4 2020Dec 31, 2020-$4.94M–
Q3 FY2020CQ3 2020Sep 30, 2020-$6.22M–
Q2 FY2020CQ2 2020Jun 30, 2020-$4.77M–
Q1 FY2020CQ1 2020Mar 31, 2020-$4.18M–
Q4 FY2019CQ4 2019Dec 31, 2019-$2.24M–
Q3 FY2019CQ3 2019Sep 30, 2019-$1.90M–
Q2 FY2019CQ2 2019Jun 30, 2019-$1.69M–
Q1 FY2019CQ1 2019Mar 31, 2019-$1.92M–
Q4 FY2017CQ2 2017Jun 30, 2017-$5.21M–
Q3 FY2017CQ1 2017Mar 31, 2017-$4.90M–
Q2 FY2017CQ4 2016Dec 31, 2016-$6.02M–
Q1 FY2017CQ3 2016Sep 30, 2016-$4.87M–
Q4 FY2016CQ2 2016Jun 30, 2016-$5.79M–
Q3 FY2016CQ1 2016Mar 31, 2016-$4.65M–
Q2 FY2016CQ4 2015Dec 31, 2015-$5.51M–
Q1 FY2016CQ3 2015Sep 30, 2015-$4.84M–
Q4 FY2015CQ2 2015Jun 30, 2015-$5.37M–

More Hepion Pharmaceuticals figures

See a number that looks wrong?